• Skip to main content
  • Skip to after header navigation
  • Skip to site footer
ERN: Emerging Researchers National Conference in STEM

ERN: Emerging Researchers National Conference in STEM

  • About
    • About AAAS
    • About the NSF
    • About the Conference
    • Partners/Supporters
    • Project Team
  • Conference
  • Abstracts
    • Undergraduate Abstract Locator
    • Graduate Abstract Locator
    • Abstract Submission Process
    • Presentation Schedules
    • Abstract Submission Guidelines
    • Presentation Guidelines
  • Travel Awards
  • Resources
    • Award Winners
    • Code of Conduct-AAAS Meetings
    • Code of Conduct-ERN Conference
    • Conference Agenda
    • Conference Materials
    • Conference Program Books
    • ERN Photo Galleries
    • Events | Opportunities
    • Exhibitor Info
    • HBCU-UP/CREST PI/PD Meeting
    • In the News
    • NSF Harassment Policy
    • Plenary Session Videos
    • Professional Development
    • Science Careers Handbook
    • Additional Resources
    • Archives
  • Engage
    • Webinars
    • ERN 10-Year Anniversary Videos
    • Plenary Session Videos
  • Contact Us
  • Login

IFN-Beta and Rig-I Induction in ADAR1 Knockout HEK 293T Cells

Undergraduate #25
Discipline: Biological Sciences
Subcategory: Microbiology/Immunology/Virology

Abigail Shilvock - Cornell University
Co-Author(s): Hachung Chung and Charles Rice, The Rockefeller University, New York, NY



Adenosine deaminases acting on RNA (ADARs) are enzymes that catalyze the most prevalent type of double stranded RNA editing in mammals. ADAR is also known to negatively regulate interferon signaling and enhance viral replication Previous experiments with mice ADAR1-/- cells demonstrated ADAR1’s role in negative regulation of interferon (IFN) signaling, but the mechanism is not clear. To further investigate ADAR1’s role and mechanism of action in human cells, the CRISPR/Cas9 system was used to generate ADAR1-/- human embryonic kidney (HEK) 293T cell lines. We then transfected both ADAR1-/- and ADAR1+/+ cell lines with polyinosinic:polycytidylic acid (poly I:C)- a double strand RNA that triggers IFN signaling. We hypothesized that ADAR1-/- cell lines would exhibit dysregulated IFN signaling upon poly I:C transfection. Our experiments show that ADAR1+/+ and ADAR1-/- cell lines have comparable levels of mRNAs for interferon beta (IFNb) and retinoic acid-inducible gene 1 (Rig-I) – an IFN stimulated gene – upon poly I:C transfection. Future directions include testing IFN signaling upon other stimuli such as virus infection.

Furthermore, this result may indicate that ADAR1 plays a role in regulating IFN signaling in a cell type specific manner, emphasizing the need to investigate other cell types besides HEK 293T cells. In addition, trying to generate knockout cell lines of the two ADAR1 isoforms, ADAR1p150 and ADAR1p110, was an ongoing aspect of this project. Access to these knockouts will allow for further experimentation to distinguish the individual functions of these isoforms.

Funder Acknowledgement(s): NIH Research Project Grant Program (R01).

Faculty Advisor: Charles Rice,

Sidebar

Abstract Locators

  • Undergraduate Abstract Locator
  • Graduate Abstract Locator

This material is based upon work supported by the National Science Foundation (NSF) under Grant No. DUE-1930047. Any opinions, findings, interpretations, conclusions or recommendations expressed in this material are those of its authors and do not represent the views of the AAAS Board of Directors, the Council of AAAS, AAAS’ membership or the National Science Foundation.

AAAS

1200 New York Ave, NW
Washington,DC 20005
202-326-6400
Contact Us
About Us

  • LinkedIn
  • Facebook
  • Instagram
  • Twitter
  • YouTube

The World’s Largest General Scientific Society

Useful Links

  • Membership
  • Careers at AAAS
  • Privacy Policy
  • Terms of Use

Focus Areas

  • Science Education
  • Science Diplomacy
  • Public Engagement
  • Careers in STEM

Focus Areas

  • Shaping Science Policy
  • Advocacy for Evidence
  • R&D Budget Analysis
  • Human Rights, Ethics & Law

© 2023 American Association for the Advancement of Science